COLGATE PALMOLIVE CO Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Colgate Palmolive Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
  • Colgate Palmolive Co Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $243M, a 31.2% decline year-over-year.
  • Colgate Palmolive Co Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $918M, a 14.9% increase year-over-year.
  • Colgate Palmolive Co annual Income Tax Expense (Benefit) for 2023 was $937M, a 35.2% increase from 2022.
  • Colgate Palmolive Co annual Income Tax Expense (Benefit) for 2022 was $693M, a 7.48% decline from 2021.
  • Colgate Palmolive Co annual Income Tax Expense (Benefit) for 2021 was $749M, a 4.83% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $918M $243M -$110M -31.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $1.03B $238M +$91M +61.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $937M $228M +$139M +156% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $798M $209M -$1M -0.48% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $799M $353M +$151M +74.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $648M $147M -$45M -23.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $693M $89M -$47M -34.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $740M $210M +$38M +22.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $702M $202M -$10M -4.72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $712M $192M -$37M -16.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $749M $136M -$66M -32.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $815M $172M -$50M -22.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $865M $212M -$4M -1.85% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $869M $229M +$82M +55.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $787M $202M +$14M +7.45% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $773M $222M +$55M +32.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $718M $216M +$11M +5.37% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $707M $147M -$67M -31.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $774M $188M -$1M -0.53% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-17
Q3 2019 $775M $167M -$91M -35.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $866M $205M -$8M -3.76% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $874M $214M -$32M -13% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $906M $189M -$354M -65.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-18
Q3 2018 $1.26B $258M +$8M +3.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $1.25B $213M -$56M -20.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $1.31B $246M -$5M -1.99% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
Q4 2017 $1.31B $543M +$237M +77.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $1.08B $250M -$50M -16.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $1.13B $269M -$12M -4.27% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $1.14B $251M -$14M -5.28% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $1.15B $306M +$31M +11.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-21
Q3 2016 $1.12B $300M -$61M -16.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $1.18B $281M -$29M -9.36% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-21
Q1 2016 $1.21B $265M -$4M -1.49% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $1.22B $275M -$50M -15.4% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-02-21
Q3 2015 $1.27B $361M -$3M -0.82% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $1.27B $310M $0 0% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $1.27B $269M +$74M +37.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $1.19B $325M +$33M +11.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $1.16B $364M +$47M +14.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $1.11B $310M +$3M +0.98% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $1.11B $195M -$44M -18.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 $1.16B $292M -$19M -6.11% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-18
Q3 2013 $1.17B $317M -$9M -2.76% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $1.18B $307M -$4M -1.29% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $1.19B $239M -$56M -19% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-25
Q4 2012 $1.24B $311M +$28M +9.89% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $1.22B $326M -$23M -6.59% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-24
Q2 2012 $1.24B $311M $0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $1.24B $295M +$3M +1.03% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $1.24B $283M +$45M +18.9% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-20
Q3 2011 $1.19B $349M +$49M +16.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-25
Q2 2011 $1.14B $311M +$7M +2.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-26
Q1 2011 $1.13B $292M +$17M +6.18% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $1.12B $238M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-21
Q3 2010 $300M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $304M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $275M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.